News & Updates

Liraglutide may have antiresorptive effect

05 Mar 2020

Use of liraglutide in patients with type 2 diabetes (T2D) does not appear to have any effect on bone resorption, even preserving bone mineral density (BMD) despite weight loss, as shown in a study.

Liraglutide may have antiresorptive effect

05 Mar 2020

Nivolumab continues positive OS, ORR track record in advanced RCC

05 Mar 2020 by

Patients with previously treated advanced or metastatic clear cell renal cell carcinoma (RCC) appear to derive greater overall survival (OS) benefit with nivolumab compared with everolimus, according to final results of the phase III CheckMate 025* trial presented at ASCO GU 2020.

Nivolumab continues positive OS, ORR track record in advanced RCC

05 Mar 2020

High-dose methylprednisolone safe, effective in severe Mycoplasma pneumoniae pneumonia

05 Mar 2020

Treatment with high-dose methylprednisolone is effective against severe Mycoplasma pneumoniae pneumonia (SMPP) and does not increase the incidence of adverse reactions, suggests a study.

High-dose methylprednisolone safe, effective in severe Mycoplasma pneumoniae pneumonia

05 Mar 2020

Pioglitazone lowers mortality risk in insulin-treated T2DM patients

05 Mar 2020

Use of pioglitazone is associated with reduced risks of all-cause mortality and noncardiovascular (non-CV) death among patients with type 2 diabetes mellitus (T2DM) who are undergoing insulin therapy, a recent study has shown.

Pioglitazone lowers mortality risk in insulin-treated T2DM patients

05 Mar 2020

Low-dose IL-2 may render therapeutic benefit for SLE

05 Mar 2020 by

Low-dose interleukin (IL)-2 therapy may be effective for the treatment of active systemic lupus erythematosus (SLE), a study has shown.

Low-dose IL-2 may render therapeutic benefit for SLE

05 Mar 2020

Water pills confer benefits to overweight, obese OSA patients with hypertension

05 Mar 2020 by

Diuretics appear to be useful in the treatment of obstructive sleep apnoea (OSA) in overweight or moderately obese patients with hypertension, producing reductions in OSA severity, body weight and blood pressure, as reported in a recent study.

Water pills confer benefits to overweight, obese OSA patients with hypertension

05 Mar 2020

Low rheumatoid factor at CZP discontinuation predicts remission maintenance in RA

05 Mar 2020

Rheumatoid arthritis (RA) patients who exhibit low rheumatoid factor (RF), as well as low disease activity, following treatment with certolizumab pegol (CZP) plus methotrexate (MTX) may be able to discontinue CZP without the increased risk of loss of remission, a recent study has shown.

Low rheumatoid factor at CZP discontinuation predicts remission maintenance in RA

05 Mar 2020

WHO: Sprayed handrub as good as poured ones, only if rubbing ensues

04 Mar 2020 by

Using alcohol-based handrub (ABHR) that is sprayed on the hand is equally effective as the one that is poured onto the hand for disinfection, but only when both are followed by hand rubbing, according to a study conducted by the WHO* Collaborating Centre on Patient Safety.

WHO: Sprayed handrub as good as poured ones, only if rubbing ensues

04 Mar 2020

Pregabalin shows promise for premature ejaculation

04 Mar 2020

At 150-mg doses, oral pregabalin appears to be effective for premature ejaculation, increasing intravaginal ejaculation latency time, a recent study has found.

Pregabalin shows promise for premature ejaculation

04 Mar 2020

Diffuse inflammation, stapled anastomosis may predict cuffitis risk

04 Mar 2020 by

Some patients with colitis are more likely than others to develop cuffitis after proctocolectomy with ileal pouch-anal anastomosis (IPAA), according to a retrospective study presented at the annual Crohn’s & Colitis Congress.

Diffuse inflammation, stapled anastomosis may predict cuffitis risk

04 Mar 2020

News & Updates

Filter by Specialty:

Specialty:

Liraglutide may have antiresorptive effect

Liraglutide may have antiresorptive effect

Nivolumab continues positive OS, ORR track record in advanced RCC

Nivolumab continues positive OS, ORR track record in advanced RCC

High-dose methylprednisolone safe, effective in severe Mycoplasma pneumoniae pneumonia

High-dose methylprednisolone safe, effective in severe Mycoplasma pneumoniae pneumonia

Pioglitazone lowers mortality risk in insulin-treated T2DM patients

Pioglitazone lowers mortality risk in insulin-treated T2DM patients

Low-dose IL-2 may render therapeutic benefit for SLE

Low-dose IL-2 may render therapeutic benefit for SLE

Water pills confer benefits to overweight, obese OSA patients with hypertension

Water pills confer benefits to overweight, obese OSA patients with hypertension

Low rheumatoid factor at CZP discontinuation predicts remission maintenance in RA

Low rheumatoid factor at CZP discontinuation predicts remission maintenance in RA

WHO: Sprayed handrub as good as poured ones, only if rubbing ensues

WHO: Sprayed handrub as good as poured ones, only if rubbing ensues

Pregabalin shows promise for premature ejaculation

Pregabalin shows promise for premature ejaculation

Diffuse inflammation, stapled anastomosis may predict cuffitis risk

Diffuse inflammation, stapled anastomosis may predict cuffitis risk